“Since HPV-related cancers take years to develop, tracking precancers offers an early indicator of the vaccine’s effectiveness,” said David M. Higgins, MD, a pediatrician and preventive medicine specialist at the University of Colorado Anschutz Medical Campus, Aurora, Colorado, in an interview.